Study Evaluating Antibody Response Of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) 24 Months After Toddler Dose.

Clinical trial NCT01026038 · COMPLETED

Trial details

NCT number: NCT01026038
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

13-valent Pneumococcal Vaccine Immunization Safety Antibody Response

Start date: 2010-04-01
Primary completion: 2010-11-01
Enrollment: 263

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.